MicroRNA‐21 as a predictor and prognostic factor for trastuzumab therapy in human epidermal growth factor receptor 2‐positive metastatic breast cancer
2018 ◽
Vol 120
(3)
◽
pp. 3459-3466
◽
2010 ◽
Vol 16
(4)
◽
pp. 1281-1288
◽
2018 ◽
2019 ◽